| News

T3 Pharmaceuticals wins W.A. de Vigier Award

28.05.2019

T3 Pharmaceuticals is among the winners of this year’s W.A. de Vigier Award. The spin-off from the University of Basel is developing a targeted cancer therapy using bacteria.

T3 Pharma (img: Universität Basel, Basile Bornand)

T3 Pharmaceuticals is among the ten winners of this year’s W.A. de Vigier Award. The Basel startup impressed the jury with its targeted cancer therapy. T3 Pharmaceuticals employ living bacteria that have the capacity to specifically find and grow in solid tumors, where the bacteria serve as efficient factories for therapeutically active proteins. The startup was founded in 2015 out of a research project at the Biozentrum of the University of Basel. T3 Pharmaceuticals is a portfolio company of BaseLaunch.

With annual prize money of 500,000 Swiss francs, the W.A. de Vigier promotional award is the oldest and most financially significant award for startups in Switzerland. To mark its 30th anniversary, the W.A. de Vigier Foundation selected twice as many startups to win the award this year. What’s more, 60 startups were able to pitch to the jury rather than the usual 16. This year’s prize money also increased to 750,000 francs overall, with some of the funds being contributed by former award winners.

“I am particularly pleased that former winners contributed to this year’s prize money. I hope that in the future our alumni will increasingly partner up with each other to help established companies remain innovative and pave the way for young startups to enter the market,” said Regula Buob, Managing Director of the W.A. de Vigier Foundation. This is all in the spirit of the founding father Bill de Vigier.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Bottmedical enters the market with innovative braces
Basel Area Business & Innovation, Innovation, Invest

Bottmedical enters the market with innovative braces

The Basel-based startup Bottmedical has developed clear braces made from bio-based polymers. After closing a successful financing round, the company...

Read More
TargImmune raises nearly 18 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

TargImmune raises nearly 18 million Swiss francs

The Basel-based biotechnology firm TargImmune has raised 17.7 million Swiss francs as part of a financing round. It now intends...

Read More
KetoSwiss launches first product in the USA
Basel Area Business & Innovation, Innovation, Invest

KetoSwiss launches first product in the USA

The Basel-based biotech startup KetoSwiss develops innovative therapies for neurological disorders. Following a successful capital increase, the company now has...

Read More
For Swiss startups, China might be closer than it seems
Basel Area Business & Innovation, Invest

For Swiss startups, China might be closer than it seems

China wants to strengthen domestic demand and be less dependent on imports. This policy has huge implications for the life...

Read More
Basel Area treads unique path
Basel Area Business & Innovation, Innovation, Invest

Basel Area treads unique path

Basel Area is responsible for both location and innovation promotion. This approach, which is unique across Switzerland, is very successful...

Read More
Alentis secures 67 million US dollars
Basel Area Business & Innovation, Innovation, Invest

Alentis secures 67 million US dollars

The Basel-based biotechnology company Alentis Therapeutics has secured 67 million US dollars in a series B funding round. The funds...

Read More
RocketVax secures partners for coronavirus vaccine in Basel
Basel Area Business & Innovation, Innovation

RocketVax secures partners for coronavirus vaccine in Basel

RocketVax has found cooperation partners for the development of its innovative coronavirus vaccine. The University Hospital of Basel, the University...

Read More
Bright Peak secures investment of 107 million dollars
Basel Area Business & Innovation, Innovation, Invest

Bright Peak secures investment of 107 million dollars

Bright Peak has raised a total of 107 million US dollars as part of a financing round. The biotechnology firm...

Read More
LCB lands major contract
Basel Area Business & Innovation, Innovation, Invest

LCB lands major contract

LCB Sàrl is active in the areas of Human Machine Interface as well as software and electronics development. The company...

Read More
1 2 3 28

Do you have a question? We'd like to hear from you.